MerTK (Innate Immune Checkpoint) Antibody MBS4380784 from MyBioSource.com

Product Specs
ItemMerTK (Innate Immune Checkpoint) Antibody
CompanyMyBioSource.com
Price $190.00Supplier Page View Company Product Page
Catalog NumberMBS4380784
ClonalityMonoclonal
TargetMerTK
NCBI Full Gene NameMER proto-oncogene, tyrosine kinase
NCBI Gene Aliasesc-Eyk, MER, Tyro12, c-mer, RP38
Conjugate/TagUnconjugated
CloneMERTK/3022
IsotypeIgG
ApplicationsImmunohistochemistry-paraffin (IHC-p)
ReactivityHuman (Hu)
PurityPurified Ab with BSA and Azide at 200ug/ml OR Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Molecular Weight110kDa
SpeciesMouse
Format200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml
Quantity0.02 mg (With BSA & Azide at 0.2mg/ml)

Specifications/Features

MerTK, also called c-Mer, is a member of the Mer/Axl/Tyro3 receptor kinase family. It is a 984 residue transmembrane protein made up of one tyrosine kinase domain, two Fibronectin type-III domains and two immunoglobulinlike C2-type domains. MerTK is the mammalian ortholog of the chicken retroviral oncogene product v-Eyk. This protein plays a critical role in macrophage activation, platelet aggregation, clot stability and the efficient removal of apoptotic cells. Specifically, MerTK acts as a signaling molecule, triggering outer segment ingestion in the retinal pigment epithelium (RPE) phagocytic process. Evidence suggests that MerTK signals via interaction with phosphatidylinositol-specific phospholipase C 2). When the gene encoding for MerTK is mutated, the RPE phagocytosis pathway is disrupted and autosomal recessive retinitis pigmentosa (RP) may result, leading to degeneration of retinal photoreceptor cells

Add to Compare List